Your browser doesn't support javascript.
loading
Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.
Oakes, Nicholas D; Thalén, Pia; Hultstrand, Therese; Jacinto, Severina; Camejo, Germán; Wallin, Boel; Ljung, Bengt.
Affiliation
  • Oakes ND; AstraZeneca R and D Mölndal, S-431 83 Mölndal, Sweden. Nick.Oakes@astrazeneca.com
Am J Physiol Regul Integr Comp Physiol ; 289(4): R938-46, 2005 Oct.
Article in En | MEDLINE | ID: mdl-16183630
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phenylpropionates / Insulin Resistance / Alkanesulfonates / Metabolic Syndrome / PPAR alpha / PPAR gamma / Lipid Metabolism / Glucose / Obesity Type of study: Prognostic_studies Limits: Animals Language: En Journal: Am J Physiol Regul Integr Comp Physiol Journal subject: FISIOLOGIA Year: 2005 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phenylpropionates / Insulin Resistance / Alkanesulfonates / Metabolic Syndrome / PPAR alpha / PPAR gamma / Lipid Metabolism / Glucose / Obesity Type of study: Prognostic_studies Limits: Animals Language: En Journal: Am J Physiol Regul Integr Comp Physiol Journal subject: FISIOLOGIA Year: 2005 Document type: Article Affiliation country: Country of publication: